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Abstract
Objective
Clue cells characteristic of bacterial vaginosis (BV) are thought to arise due to exfoliation of
the vaginal epithelium; however, there is little published data connecting total numbers of
epithelial cells to markers of BV. The purpose of this study was to enumerate exfoliated epi-
thelial cells (independent of clue cells) and examine the relationship to Nugent score.
Study design
We conducted a cross-sectional sub-study of the Contraceptive CHOICE Project cohort.
Vaginal swabs were used to create vaginal smears for Gram staining and these smears
were later scored using the Nugent method, and then two blinded observers used micros-
copy to enumerate exfoliated epithelial cells. The degree of epithelial cell exfoliation was
compared between women diagnosed as BV-negative (Nugent score 0–3), BV-intermediate
(Nugent score 4–6), and BV-positive (Nugent score 7–10). BV specimens (Nugent 7–10)
were randomly matched to specimens in the two other groups (Nugent low and Nugent-
intermediate), in order to avoid comparing groups of women with potentially confounding
baseline demographics.
Results
Exfoliated epithelial cell counts were higher in the vaginal smears from BV-positive women
compared with BV-negative women. Higher levels of epithelial exfoliation were also evident
in BV-intermediate women compared to those with low Nugent scores. After adjustment for
clustering introduced by matching, the incidence ratio of increased epithelial cell counts was
2.09 (95% CI 1.50–2.90) for the BV-intermediate women and 1.71 (95% CI 1.23–2.38) for
the BV positive women.
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Conclusion
A vaginal epithelial exfoliation phenotype was measured in both Nugent-defined BV-positive
and BV-intermediate women. Bacterial vaginosis and intermediate status (Nugent score >3)
was associated with significantly more vaginal epithelial exfoliation compared to women
with Lactobacillus-dominated microbiotas (Nugent 0–3).
Introduction
The healthy human vagina is host to a Lactobacillus-dominated microbiota, which appears to
have a critical role in thwarting colonization or infection by bacteria, viruses, and parasites
that have been linked with negative health outcomes [1]. Approximately one in three women
in the U.S. have bacterial vaginosis (BV) [2], a condition characterized by few lactobacilli, and
an overgrowth of a diverse mixture of fastidious anaerobes. Many epidemiological studies
have shown BV to be associated with increased risk of sexually transmitted infections (e.g.,
gonorrhea, chlamydia, HIV, trichomoniasis), and pelvic inflammatory disease [3–7]. In preg-
nancy, BV has been associated with infections of the placenta and amniotic fluid and with pre-
term birth [8–12]. However, despite the clinical implications of BV, little is known about its
etiology.
BV is an imbalance of the vaginal microbiota and was defined in the 1980s as a diagnostic
entity. In the clinical setting, BV may present asymptomatically, but it is often accompanied by
increased pH, thin vaginal discharge, fishy odor, and the presence of “clue” cells, which are
vaginal epithelial cells covered in bacteria [13]. Presently, the gold standard for laboratory-
based BV diagnosis is the Nugent scoring method [14]. By this method, Gram stained smears
of vaginal fluid are quantified for the presence of Gram positive ‘beneficial’ Lactobacillus mor-
photypes as compared to Gram negative organisms and Gram variable Actinobacteria such as
Gardnerella, Atopobium and Mobiluncus. This approach results in an overall score in which
0–3 indicates a “normal” lactobacilli-dominated microbiota, 7–10 indicates BV, and the score
of 4–6 has been referred to as an “intermediate microbiota” whose significance is incompletely
characterized. Collectively, samples yielding a Nugent score greater than 3, i.e. both intermedi-
ate and BV together, have been referred to as “abnormal” vaginal flora or microbiota [7, 15,
16].
It has long been thought that clue cells, one of the clinical features of BV, are the result of an
exfoliation of the vaginal epithelium in the presence of BV-associated bacteria [17, 18]. How-
ever, until recently there was little quantitative evidence to support this common assertion.
Recently, we examined the quantity of epithelial cells present in human clinical vaginal smears
and reported that specimens from women with Nugent-defined BV (score 7–10) exhibited sig-
nificantly more exfoliated epithelial cells than women with a Lactobacillus-dominant micro-
biota (Nugent scores 0–3)[19].
This previous study had some potential limitations. First, there was no matching performed
in the study. Given the higher risk of BV among African-American women, it is possible that
race could be a confounder. The previous study also did not examine exfoliation across the
entire range of Nugent scores (Nugent-defined intermediate scores of 4 to 6 were not studied).
Interestingly, women with intermediate Nugent scores, like those with high Nugent scores,
have been shown to have higher risks of sexually transmitted infections [7, 20–22], suggesting
that shared features of the microbiology in women with Nugent scores greater than 3 may be
responsible for increased susceptibility to secondary infection. Here, we sought to confirm the
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earlier finding of increased epithelial exfoliation among women with BV and to expand on the
previous findings to determine if increased epithelial exfoliation is a shared feature of vaginal
microbiomes with Nugent score greater than 3.
We used a matched cross-sectional design in which women defined as BV-positive (Nugent
7–10), BV-negative (Nugent 0–3), and BV intermediate (Nugent 4–6) were matched on the
basis of age, race, and lifetime number of sexual partners. The aim of the present study was to
quantify the extent of epithelial exfoliation in clinical specimens representing all three Nugent-
defined categories.
Materials and methods
Study design
This is a cross-sectional study with matching that uses samples and questionnaire data from
women enrolled in the Contraceptive CHOICE Project (CHOICE). CHOICE received
approval from the IRB at Washington University School of Medicine. Written informed con-
sent from all participants was obtained at enrollment, as well as permission to use vaginal sam-
ples for future studies. This sub-project received IRB approval (ID # 201108155) first in 2011;
the most recent continuing review was in January 2016. Both the parent study (CHOICE) and
this sub project were conducted according to the principles expressed in the Declaration of
Helsinki.
From August 2007 to September 2011, a total of 9256 St. Louis-area women were screened
and enrolled through CHOICE-affiliated clinical sites. CHOICE inclusion criteria were:
reported sexual activity in the past six months or anticipated sexual activity with a male partner
and the desire to prevent pregnancy by use of contraception. Exclusion criteria were ages out-
side the 14–45 year age range and history of tubal ligation or hysterectomy, as previously
described [23].
Women who had a complete baseline survey and vaginal swab collected were eligible for
this analysis. We excluded women who reported a race other than white or black. We note that
few individuals enrolled in the CHOICE study self-identified in groups other than white” or
black and that demographic characteristics of the CHOICE study were representative of the
St. Louis region as a whole. Women with current Chlamydia trachomatis, Neisseria gonor-
rhoeae, or Trichomonas vaginalis infection were excluded to reduce the possibility of con-
founding variables that may also influence epithelial exfoliation. From the eligible individuals,
100 women with Nugent-defined BV (Nugent score 7–10) were chosen at random and were
matched by age, race, and lifetime number of sexual partners to two controls, one in each of
the Nugent categories “low” (0–3) and “intermediate” (4–6). In general, the Nugent scoring
system combines bacterial morphotypes together with Gram staining properties to reflect the
overall character of the vaginal microbiota [14]. Briefly, Nugent scoring occurs on a scale of 0
to 10 and has three components: 1) a score of 0–4 reflecting the presence of rod-shaped Gram
positive lactobacilli where 0 indicates highest numbers, 2) a score of 0–4 reflecting the num-
bers of Gram negative and Gram variable bacteria where 4 indicates highest numbers, and 3) a
score of 0–2 reflecting the presence of curved rods. Women were matched based on the risk
factors of race and total number of sexual partners as well as by age, in order to avoid differ-
ences in vaginal physiology that may change over a woman’s reproductive years.
Matching was performed using a greedy matching algorithm; this approach selects a ran-
dom match from the group of closest matches. Matches were exact match for race, had an age
within 2 years, and a comparable number of lifetime number of sexual partners (exact matches
to bins of 0–2, 3–7, 8–12, 13–17, 18–22, and 23+). After excluding matched sets in which one
or more vaginal samples were not available for study, there were a total of 50 matched sets (150
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women total). Our previous analysis of exfoliation suggested that we would be powered to
observe differences in exfoliation with this number of matched participants.
Upon enrollment in CHOICE, women were instructed on a self-collection protocol and
provided a double-headed rayon swab (Starplex Scientific Inc, Etobicoke, Ontario, Canada)
for vaginal sample collection. One of these swabs was rolled on a glass slide which was Gram
stained for Nugent scoring and epithelial exfoliation analysis. All swabs were rolled by the
same technician to ensure consistency in application of biological material to the slides. As
with any study performed on vaginal samples, different swabs will have somewhat different
amounts of biological material. However, we note that all stained vaginal smears should con-
tain some visible mucus, bacteria, and/or human cells. When this was not the case, we marked
the samples as having too little biological material for proper analysis. Samples without an
available Nugent score were excluded from our study.
Epithelial exfoliation
Epithelial cell numbers were quantified from heat-fixed, Gram stained vaginal fluid slides as
provided by CHOICE. Slides were visualized with a 10x objective on an Olympus BX61 micro-
scope for a total magnification of 100x, and three representative images were captured from
each specimen slide using StreamStart1 software. Representative images were taken from
locations on the slide that contained biological material. The images were not taken from loca-
tions on the slide near the start or end of the vaginal swab smears because these locations
would have inconsistent and often large amounts of biological material. Exfoliated epithelial
cells (all epithelial cells, not just clue cells) were then enumerated from the images by two inde-
pendent observers who were blinded to Nugent score data. The three counts by two observers
were summarized using a single harmonic mean, with counts of zero set to the limit of detec-
tion (one). Nugent scoring and epithelial enumeration were performed by different individu-
als. Epithelial cell enumerators never received training on Nugent scoring, and thus, were truly
blinded to Nugent status.
In this study, we re-used Gram-stained slides previously employed for Nugent scoring and
here analyzed the samples using a lower magnification. Exfoliated epithelial cells were enumer-
ated using the same Gram stained slides used for prior Nugent scoring. As mentioned previ-
ously, the Nugent strategy is a validated and widely used method for bacterial morphotype
scoring that provides a laboratory method for diagnosing BV. Thus, using the same slide for
epithelial enumeration provides greater confidence that the numbers of epithelial cells are not
solely a function of the amount of biological material present on a swab or deposited on a
slide.
Statistical analysis
Categorical variables were compared using either chi-square statistics or Fisher’s exact tests, as
appropriate. Potential confounders (listed in Table 1) were evaluated for association with out-
come (epithelial exfoliation) and exposure (BV status/Nugent score). Criteria for confounding
variables were: significance with both outcome and exposure at the alpha < 0.05 level for
inclusion in adjusted regression models; and change in beta for the exposure variable of inter-
est by 10% or more for inclusion in final models. No variables met these criteria, so unadjusted
models are presented. Poisson regression models of epithelial counts were used to estimate
incidence rate ratios (IRR) for BV status and Nugent score. Linear and Poisson regression
models adjusted for clustering were used to factor-in the clustering introduced by matching
BV positive specimens to negative and intermediate specimens using cluster-robust standard
errors using the vce(cluster) option [24, 25]. These analyses were completed using Stata
Nugent score and vaginal exfoliation
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(version 13.1, Stata Corp, College Station, TX). GraphPad Prism 7.0 software was used to gen-
erate Fig 1. In addition to the analyses above, epithelial counts were compared between
Nugent defined groups using the Friedman test (D’Agostino & Pearson normality test indi-
cated that epithelial count data from all three groups were not normally distributed), followed
by post hoc analysis using Dunn’s multiple comparisons test (analyses were performed in
Prism).
Results
Participant characteristics
The demographic and reproductive characteristics of women in the study are shown in
Table 1. The average age of participants was 25.2 years and 76% of participants self-identified
as black. Nineteen percent of women reported 8–12 lifetime sexual partners, while 14%
reported 13 or more partners. Thirty-five percent of women reported a history of smoking
with 20% reporting current smoking at enrollment. Participants did not differ significantly by
BV status in terms of current contraceptive method prior to enrollment, smoking history,
douching in the prior 30 or 180 days or self-reported vaginal symptoms in the past 7 days
(abnormal discharge, odor or itching, see S1 Table).
Nugent scores greater than three are associated with higher epithelial
cell numbers in vaginal fluid
Significantly higher numbers of exfoliated epithelial cells were measured in BV-positive
women (Nugent 7–10) compared to their BV-negative (Nugent 0–3) counterparts (Fig 1).
Nugent-defined intermediate status (scores 4–6) was also associated with significantly more
epithelial exfoliation than matched BV-negative patients (Fig 1). Observed counts of exfoliated
Table 1. Characteristics of women from the Contraceptive CHOICE Project included in matched*
analysis, N = 150.
BV (-) BV (int.) BV (+) P-value
N 50 50 50
N (%) N (%) N (%)
Contraception prior to enrollment 0.79
No method 10 (20) 10 (20) 9 (18)
Modern 18 (36) 13 (26) 13 (26)
Condom 17 (34) 18 (38) 23 (46)
Other 5 (10) 8 (16) 5 (10)
Smoking status 0.48
Never 33 (66) 32 (64) 32 (64)
Past 10 (20) 8 (16) 5 (10)
Current 7 (14) 10 (20) 13 (26)
Douched in past 30 days 2 (4) 4 (8) 6 (12) 0.34
Douched in past 180 days 5 (10) 10 (20) 14 (28) 0.07
Self-reported in past 7 days
Discharge 7 (14) 9 (18) 8 (16) 0.86
Abnormal odor** 1 (2) 4 (8) 3(6) 0.53
Abnormal itching** 4 (8) 1 (2) 0 0.13
*Matched age (within two years), race, and number of sexual partners
**P-value using Fisher’s exact
https://doi.org/10.1371/journal.pone.0177797.t001
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cells were modestly higher among the BV intermediate group compared with BV-positive par-
ticipants, but there was no statistically significant difference between these groups. After
adjustment for clustering introduced by matching, the incidence rate ratios for the BV inter-
mediate and BV positive groups (compared to the BV negative group) were 2.09 (95% CI
1.50–2.90) and 1.71 (95% CI 1.23–2.38), respectively. In other words, women with Nugent
Fig 1. Relationship between Nugent score and epithelial exfoliation. Number of exfoliated epithelial cells by
Nugent-defined BV group (negative, intermediate, and positive) is plotted as the harmonic mean of six counts from
two observers. “Int.” = intermediate; “ns” = not significant. The central tendencies and error bars shown are
medians and interquartile ranges respectively. The Friedman test (P < 0.01) was used to compare differences
between groups, followed by Dunn’s multiple comparison post hoc test (** P < 0.01, * P < 0.05).
https://doi.org/10.1371/journal.pone.0177797.g001
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scores of four or greater have ~1.7- to 2-fold more exfoliated epithelial cells than women with
low Nugent scores. See S2 Table for the raw data underlying these findings. Demographic vari-
ables, types of contraception used, and behaviors such as smoking and douching were evalu-
ated as potential confounders; however, none of these variables achieved significance for both
outcome and exposure at the alpha< 0.05 level (see S1 Table).
Discussion
Many studies of bacterial vaginosis describe the presence of clue cells as evidence of a vaginal
epithelial exfoliation response. Here, we tested whether the total number of epithelial cells in
vaginal specimens varied as a function of the vaginal microbiota (independent of the presence
or numbers of clue cells). In this study, we show a correlation between total epithelial exfolia-
tion (cell counts in vaginal specimens) and BV (women with Nugent scores of 7–10 had higher
levels of epithelial cells compared to women with scores of 0–3). In fact, epithelial exfoliation
was not specific to BV. Rather, women with Nugent scores greater than or equal to 4 had
higher levels of epithelial cells in vaginal specimens compared to BV-negative women. We
emphasize that our measures of exfoliation were not limited to epithelial “clue” cells; rather, all
epithelial cells were counted to estimate the extent of exfoliation in relation to Nugent criteria.
The fact that BV-positive and BV-intermediate were phenotypically and statistically indistin-
guishable with respect to epithelial exfoliation is consistent with a role for Gram negative bacteria
and Actinobacteria in BV pathophysiology. Typically, the difference between women who score
as intermediate (4–6), versus those who have Nugent-defined BV (7–10) lies in the amount of
lactobacilli present. Whereas intermediate women have some lactobacilli, women with BV have
many fewer or absent lactobacilli. On the other hand, BV and intermediate women typically
share the common feature of higher levels of bacteria that are phenotypically Gram negative or
that vary morphologically from the distinct large rod-shaped lactobacilli. Thus, the presence of
the exfoliation in Nugent intermediate women argues against the absence of lactobacilli as a
driver of this phenotype. The finding that Nugent-defined BV and intermediate samples share
an exfoliation response is consistent with a causal role for these organisms, whose overgrowth
has been associated with BV.
Indeed, this interpretation parallels our previous findings in a mouse model, showing that
G. vaginalis can elicit an exfoliation response of the vaginal epithelium [19]. In this previous
model, we showed that infected animals exhibited a significantly higher number of epithelial
cells in vaginal washes compared to mock infected animals. The animal model also exhibited
several other clinical features of BV, including vaginal bacterial sialidase activity and vaginal
mucus degradation.
Our analysis is based on stored specimens. We did not assess the association of exfoliation
and Amsel’s criteria as these data were not readily available for analysis. Since clue cells have
been defined according to their presence at the point of care in wet mount microscopy, which
must be performed on fresh vaginal secretions, we were unable to perform a comparison of
the amounts of clue cells in relation to the total number of exfoliated cells.
In the current study, epithelial counts and Nugent score were derived from the same Gram-
stained slide examined at a different magnification. We acknowledge the possibility that BV
could result in inherent differences in the type and/or quantity of biological material collected
by vaginal swabbing, or that procedure of Gram-staining could influence epithelial cells differ-
ently because of inherent biological differences in samples from women with and without BV.
However, as noted in the Materials and Methods, swabs take up a limited volume far below the
total volume of vaginal fluid available. Studies by previous researchers estimate that women
produce vaginal fluid at volumes between 4.5 to 7.9 mL per day [26], whereas swabs have a
Nugent score and vaginal exfoliation
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limited capacity at least an order of magnitude below this. Previous studies have shown a very
good agreement between Nugent scores and Nugent-based BV diagnosis when comparing
self-collected versus provider-collected samples, including studies involving pregnant [27] and
nonpregnant [28, 29] women. Self-collected vaginal swabs also result in nearly identical 16S-
rDNA-based bacterial community profiles as physician collected swabs [30]. Taken together,
these findings argue that (1) uniform use of the same swabs (Starplex) across all women in the
study should result in the collection of similar amounts of biological material, and (2) that the
biological material sampled during self-collection of vaginal swabs is indistinguishable from
clinician-collected material in terms of Nugent score and microbial community profiles. We
also acknowledge that self-collection of vaginal swabs may limit the study by introducing more
variation between samples, for example if some participants swab more rigorously than others.
However, this is a concern that could also apply to contexts where multiple clinicians collect
material from participants.
In the present study, possible confounding factors might include variables such as smoking
status, which was previously shown to be associated with increased cervicovaginal epithelial
exfoliation [31, 32]. Other studies have identified smoking as a risk factor for BV [33, 34]. Our
study sample contained relatively few (20%) current smokers. Nonetheless, tobacco use and
other potential confounders (listed in Table 1) were evaluated for association with outcome
(epithelial exfoliation) and exposure (BV status/Nugent score). None of these variables achieved
significance for both outcome and exposure at the alpha< 0.05 level (see S1 Table).
Another potential weakness of our study is a relatively low racial diversity of our partici-
pants, with 76% being black. As noted in the Materials and methods section, the demographic
characteristics of the CHOICE study were representative of the St. Louis region (approxi-
mately half black and half white). Considering the fact that black women are differentially
impacted by BV, they were over-represented in this study. Future studies would need to assess
potential differences in exfoliation among different demographic groups from diverse geo-
graphic locations.
The relationship between exfoliation and intermediate Nugent score is a new finding with
potential clinical implications. Recent studies using modern sequencing technology have mea-
sured the levels of different bacteria implicated in BV and compared these data across Nugent
scores. These studies demonstrate that women with intermediate Nugent scores also tend to
have high levels of BV bacteria measured by quantitative molecular methods [35, 36]. The
finding of greater exfoliation in women with intermediate Nugent scores may explain previous
findings that these women, like their BV-positive counterparts, are at increased risk of acquir-
ing sexually transmitted infections (trichomoniasis, HIV, and gonorrhea) compared to women
with Nugent scores 0–3[7, 20–22]. Our data suggest that epithelial exfoliation may be a host
response to elevated numbers of BV bacteria, or the results of the action of bacterial virulence
factors on epithelial cells, even if women do not meet the full Nugent criteria for BV (i.e. very
low numbers of lactobacilli). Results of several previous studies suggest that certain detergents
used in personal lubricants (e.g. nonoxynol-9) stimulate rapid epithelial exfoliation, a finding
that may underlie the failure of such products to protect their users from HIV infection,
despite their ability to disrupt viral membranes [37–40]. Further studies should explore
whether epithelial exfoliation exposes niches in which sexually transmitted pathogens more
easily gain or maintain residence in the reproductive tract.
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S1 Table. Crude and adjusted associations with epithelial cell counts.
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